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Mammalian cell membranes regulate homeostasis, protein activity, and cell signaling.
The charge at the membrane surface has been correlated with these key events.
Although mammalian cells are known to be slightly anionic, quantitative information on the
membrane charge and the importance of electrostatic interactions in pharmacokinetics
and pharmacodynamics remain elusive. Recently, we reported for the first time that
brain endothelial cells (EC) are more negatively charged than human umbilical cord cells,
using zeta-potential measurements by dynamic light scattering. Here, we hypothesize
that anionicity is a key feature of the blood-brain barrier (BBB) and contributes to select
which compounds cross into the brain. For the sake of comparison, we also studied
the membrane surface charge of blood components—red blood cells (RBC), platelets,
and peripheral blood mononuclear cells (PBMC). To further quantitatively correlate the
negative zeta-potential values with membrane charge density, model membranes with
different percentages of anionic lipids were also evaluated. From all the cells tested, brain
cell membranes are the most anionic and those having their lipids mostly exposed, which
explains why lipophilic cationic compounds are more prone to cross the blood-brain barrier.
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INTRODUCTION
Membranes are not considered anymore as mere barriers limit-
ing the cellular content. An increased complexity of membrane
composition, dynamics and functionality has been recognized
in recent years. Membrane surface charge, which is the cumula-
tive effect of charged proteins, ions, and lipid headgroups on the
membrane, seems to play an essential role in this functionality,
with a crucial part in homeostasis and protein targeting, among
other processes (Goldenberg and Steinberg, 2010).
Mammalian cell membranes are generally known to be
anionic, but a comprehensive study of their charge density has
never been performed. First reports and concerns about the
charge of cells appeared in the 1960’s. Most of these initial stud-
ies evaluated the electrophoretic mobility and were performed
for red blood cells (RBC). Elul (1967) was the first to observe
that the negative electrostatic charge of RBC is located at fixed
positions on the cell surface. Such negative charge was mainly
attributed to the presence of sialic acid residues at the mem-
brane level (Eylar et al., 1962). These authors also reported that
no significant differences existed between species and cell types.
In the last decades, the development of the biological and
biomedical applications of dynamic light scattering approaches
Abbreviations: RBC, red blood cells; EC, endothelial cells; BCEC, brain capillary
endothelial cells; HUVEC, human umbilical vein endothelial cells; TMA-DPH, 1-
[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene; PBMC, peripheral blood
mononuclear cells; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
PRP, platelet-rich plasma; LUVs, large unilamellar vesicles; POPC, 1-palmitoyl-
2-oleyol-sn-glycero-3-phosphocoline; POPG, 1-palmitoyl-2-oleyl-sn-glycero-3-
[phosphor-rac-(1-glycerol)]; PBS, phosphate buffered saline; SEM, standard
error of the mean; BBB, blood brain barrier; PS, phosphatidylserine, PI,
phosphatidylinositol; PC, phosphatidylcholine; SM, sphingomyelin; PE, phos-
phastidylethanolamine.
brought new insights to this field. In the absence of a direct
measurement of the surface charge, zeta-potential has proven to
be very useful. Using this technique, some authors showed that
RBC from human diabetic patients exhibited lower zeta-potential
values than RBC from healthy donors (Adak et al., 2008). A cor-
relation between increased zeta-potential and aging of RBC was
also reported (Chen et al., 2007; Carvalho et al., 2011). As the
dependence of hematology unbalance on alterations in mem-
brane surface charge of cells became evident, an increased interest
in the interaction between vascular endothelial cells (EC) and
blood components emerged. Moreover, vascular permeability to
macromolecules seemed to be dependent not only on molecu-
lar size but also on the electrostatic charge (Klein et al., 1992).
As a matter of fact, many studies show that cationic compounds
have an increased tendency to translocate cellular membranes,
relative to anionic compounds. A clear example resides on the
cell penetrating peptides, a cationic class of compounds that have
been successfully used for drug delivery into mammalian cells
(Henriques et al., 2006).
We recently characterized the membrane surface charge of
EC from two different origins: bovine brain capillary endothe-
lial cells (BCEC) and human umbilical vascular endothelial cells
(HUVEC), and their interaction with analgesic peptides through
zeta-potential measurements (Ribeiro et al., 2011). The use of
human primary brain cells is hampered both by ethical and
technical issues, and immortalized cell lines display an elevated
expression of phosphatidylserine (PS) in the outer leaflet of the
cell membrane when compared to normal cells, and therefore,
would not provide a truthful zeta-potential value (Zwaal et al.,
2005). For these reasons, we decided to use bovine cells due
to brain size, availability, performance, and strong correlation
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with human in vivo data (Gumbleton and Audus, 2001; Garberg
et al., 2005). BCEC membranes revealed to be more anionic
than HUVEC membranes. In addition, BCEC showed a pref-
erential interaction with a peptide that combined cationic and
lipophilic characteristics. Now, we hypothesize that anionicity
is a distinctive feature of brain endothelium. Confirmation or
rebuttal of such hypothesis requires a comparative study of the
anionicity of the cells’ membranes that are exposed to drugs
during their systemic distribution along the bloodstream—RBC,
platelets, and leukocytes, such as peripheral blood mononu-
clear cells (PBMC). In addition, several drugs are incorpo-
rated in the RBC, largely reducing their bioavailability and
further reinforcing the need to map the factors that govern
the interaction of drugs with the cell membranes they con-
tact with.
In the present work, we used zeta-potential measurements
by dynamic light scattering to quantify the membrane surface
charge of themain blood cellular components: RBC, platelets, and
PBMC, and compared these with the values previously obtained
for BCEC and HUVEC. For the sake of simplicity, we also per-
formed experiments with membrane model systems so that an
intuitive anionicity scale can be used as a working tool. Our
results show that BCEC possess the most negatively charged
membrane. All blood components display similar zeta-potential
values and these do not differ fromHUVECmembranes, suggest-
ing that electrostatic repulse between vascular endothelium and
blood components is crucial for maintaining homeostasis.
MATERIALS AND METHODS
BLOOD
Human blood samples were obtained from adult healthy volun-
teers, at the public blood bank Instituto Português do Sangue
(IPS, Lisbon, Portugal), with their previous informed written
consent, under an institutional agreement between IPS and
the Instituto de Bioquímica of the Faculdade de Medicina da
Universidade de Lisboa (FMUL). This study was approved by
the FMUL Ethics Committee. Blood was collected into K3EDTA
anticoagulant tubes (Vacuette, Greiner Bio-one, Kremsmünster,
Austria).
BLOOD COMPONENTS ISOLATION
Total erythrocyte population was separated from the other blood
components by centrifugation at 200 g for 10min, at room
temperature. Erythrocytes were washed three times with 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer,
pH 7.4, and centrifuged at 2000 g for 10min. This process was
repeated twice. Packed erythrocytes were re-suspended in the
same buffer and diluted for a final hematocrit of 0.0035%,
corresponding approximately to 4 × 108 RBC/L. Zeta-potential
measurements were performed with 4 × 105 RBC/mL in HEPES
buffer.
Platelets were isolated from platelet-rich plasma (PRP). Briefly,
PRP was separated by centrifugations at 220 g for 7min, at 10◦C.
Platelets were pelleted from PRP at 1620 g for 10min, at 10◦C,
and washed three times with HEPES buffer. The final pellet was
re-suspended in 1mL and counted. Zeta-potential measurements
were conducted with 4 × 106 platelets/mL in HEPES buffer.
PBMC were isolated by density gradient using Ficoll-Paque
Plus (GE Healthcare, Little Chalfont, UK), accordingly to manu-
facturer’s instructions. Cells were counted at the microscope with
trypan blue and were used for zeta-potential measurements at
4 × 105 cells/mL in HEPES buffer.
LIPID VESICLES PREPARATION
Large unilamellar vesicles (LUVs) with approximately 100 nm
diameter were used. For LUVs preparation, lipids were dissolved
in chloroform and the solvent was removed to yield a lipid film.
After addition of buffer, hydrated lipid sheets detach sponta-
neously. Upon agitation and freeze-thaw cycles, a suspension of
multilamellar vesicles was obtained and further extruded to pro-
duce LUVs (Mayer et al., 1986). LUVs have a lipid packing close
to planar membrane due to their larger radii of curvature relative
to molecular dimensions and are more stable than other vesicles,
making them ideal mammalian membrane models. Also, LUVs
inner and outer layers display similar superficial areas (Ribeiro
et al., 2010). These vesicles can be easily produced with different
biologically relevant lipid compositions (e.g., presence of charged
phospholipids or different cholesterol content), accounting for
the contributions of hydrophobic and electrostatic interactions,
membrane fluidity, and phase separation, or can even be prepared
directly from lipids extracted from a certain type of cell. Here,
systems constituted by POPC (1-palmitoyl-2-oleyol-sn-glycero-
3-phosphocoline) and POPG {1-palmitoyl-2-oleyl-sn-glycero-3-
[phosphor-rac-(1-glycerol)]} were studied with the following
proportions: 95:5, 90:10, and 85:15. Zeta-potential measurements
were conducted with a lipid composition of 200μM, in phos-
phate buffered saline (PBS, pH 7.4). LUVs constituted by pure
POPC or POPC:POPG 80:20, 60:40, and 40:60 were also evalu-
ated to characterize the relationship between zeta-potential values
and the total anionic percentage of lipid in the membrane bilayer.
ZETA-POTENTIAL MEASUREMENTS
Measurements were conducted on a dynamic light scatter-
ing and zeta-potential Malvern Zetasizer Nano ZS equipment
(Malvern, UK), with a He-Ne laser (λ = 632.8 nm). The zeta-
potential (ζ) of the samples was determined, at 25◦C, from
the mean of a minimum of 15 measurements (60 runs each),
with 90 s in between measurements, with an applied poten-
tial of 40 V, using disposable zeta-potential cells with plat-
inum gold-coated electrodes (Malvern, UK). Samples were
incubated in the cell holder for 15min prior to measure-
ment. 1-[4-(Trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene
(TMA-DPH, Invitrogen) was added for a final concentra-
tion of 54μM and incubated for 30min previous to mea-
surements to allow complete equilibration of TMA-DPH with
cells or LUVs. Each represented group value is an aver-
age of at least two independent measurements. The elec-
trophoretic mobility obtained was used for the zeta-potential cal-
culation through the Smoluchowski equation (Domingues et al.,
2008).
ζ = 4πημ
ε
(1)
where μ represents the electrophoretic mobility, η the viscosity
of the solvent and ε its dielectric constant. The viscosity of all
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tested samples was similar, despite the differences in the cells’
concentration used; turbidity was kept below the threshold
that significantly attenuates the incident light intensity in the
sample and samples were prepared in the same buffer (Anderson,
1981; Castanho et al., 1997; Delgado et al., 2005; Kaszuba et al.,
2010). Therefore, in the experimental conditions used, the slight
concentration differences between samples evaluated do not
influence zeta-potential measurements.
STATISTICAL ANALYSIS
Data are expressed as mean ± standard error of the mean
(SEM). Each group value is an average of at least two indepen-
dent measurements. The significance of differences in each group
between control and TMA-DPH treated cells/vesicles was evalu-
ated by Student’s t-test. The significance of differences between
cell types/vesicles with distinct composition was analyzed with
One-Way ANOVA followed by Bonferroni’s multiple comparison
test. All statistical analyses were calculated with Prism software
(GraphPad Software, version 5).
RESULTS
ZETA-POTENTIAL OF BLOOD COMPONENTS
Although there are a few reports regarding the membrane sur-
face charge of some RBC populations, a simultaneous approach
to all blood components in the same experimental conditions to
the best of our knowledge has never been performed. To charac-
terize the membrane surface charge of RBC, platelets, and PBMC,
these constituents were isolated and their zeta-potential values
measured (Table 1).
As shown in Figure 1A, all blood components display sim-
ilar zeta-potential values, between −10.75mV (platelets) and
−11.95mV (PBMC). Furthermore, zeta-potential of HUVEC
(Ribeiro et al., 2011) is within the same range of values as RBC,
platelets, and PBMC. The similar charge between blood com-
ponents and vascular endothelium causes a constant repulsion
between these cells.
To test the ability of zeta-potential to report electrostatic
interactions in the cells’ surfaces, we used as a positive control
TMA-DPH, a probe of membrane dynamics in living cells. It is
a cationic probe (+1), due to its –NH+3 moiety that intercalates
at the level of hydrophilic head groups of membrane phospho-
lipids, increasing the electrostatic charge of the outer layer of
the cell membrane (Figure 1B). Upon interaction, TMA-DPH is
expected to contribute to reduce anionicity of the cell membrane.
After incubation with TMA-DPH, only PBMC did not present
a significant change on the zeta-potential value (Figure 1A).
PBMC have a high immune activity, constantly recognizing
and destroying exogenous pathogens. These defense mecha-
nisms may explain the lack of differences between unlabeled
and TMA-DPH treated PBMC. On the other hand, TMA-DPH
incubation with RBC resulted in the higher difference observed
between control and TMA-DPH treated cells. The extent of this
variation can be appraised through ζ = ζTMA−DPH – ζbuffer
(Table 1). In fact, ζ of RBC changed from negative (−10.80 ±
1.634mV, buffer) to positive values (2.37 ± 0.787mV, 54μM
TMA-DPH), resulting in ζ = 13.17 ± 2.42mV. This consider-
able alteration in the zeta-potential, which can be understood
Table 1 | Zeta-potential of blood components, endothelial cells, and
membrane model systems constituted by POPC and POPG.
ζ (mV) ζ (mV)
BLOOD COMPONENTS
RBC Buffer −10.80±1.63 13.17±2.42
TMA-DPH 2.37±0.79
Platelets Buffer −10.75±1.17 1.43±2.12
TMA-DPH −9.33±0.96
PBMC Buffer −11.95±0.66 1.25±1.79
TMA-DPH −10.70±1.13
ENDOTHELIAL CELLS
BCEC Buffer −15.28±0.58 3.15±1.07
TMA-DPH −12.13±0.49
HUVEC Buffer −12.89±0.56 1.74±1.05
TMA-DPH −11.15±0.49
LUVs
5% POPG Buffer −7.06±1.33 12.87±3.35
TMA-DPH 5.82±2.02
10% POPG Buffer −12.60±0.63 9.88±1.50
TMA-DPH −2.73±0.87
15% POPG Buffer −19.80±0.66 11.59±2.16
TMA-DPH −8.21±1.50
Cells or LUVs were incubated with TMA-DPH for a final concentration of 54 μM
at 25◦C and zeta-potential was measured. RBC (4 × 105 cells/mL), platelets
(4 × 106 platelets/mL), PBMC (4 × 105 cells/mL), HUVEC and BCEC (Ribeiro
et al., 2011), and LUVs (200 μM) concentrations were kept constant. Data shown
as mean ± SEM; each group value is an average of at least two independent
measurements.
in terms of TMA-DPH affinity toward the RBC membrane,
indicates an entrapment of the probe beyond electrostatic equiv-
alence.
When put together, these results show that from all the cells
tested, BCEC display the most negative membrane charge. In
addition, BCEC interaction with TMA-DPH was also extremely
significant (P < 0.001), which indicates that zeta-potential is an
adequate technique to assess the membrane charge of these cells
and to report the interaction with cationic molecules.
ZETA-POTENTIAL OF LUVs
To have a semi-quantitative correlation between ζ and membrane
charge, we used cell membrane model systems—LUVs—and
measured their zeta-potential values. Mixtures of fluid zwit-
terionic POPC with anionic POPG (up to 60%) were used.
Electrostatic interactions are expected to be independent from
the nature of the anionic lipid (Buser et al., 1994). As expected,
increased POPG concentration in the membrane resulted in
more negative zeta-potential values (Figures 2 and 3). Figure 2
shows that a drop in ζ from −10mV (RBC, PBMC, platelets,
HUVEC) to −15mV corresponds to an apparent change in
anionic net surface charge density of roughly 2-fold, which is
extremely significant when interaction with cationic drugs is
considered.
Incubation with TMA-DPH (Figure 3) promoted the alter-
ation of zeta-potential toward neutralization and in the case of 5%
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FIGURE 1 | Zeta-potential of blood components and endothelial cells
of mammals in the absence and in the presence of TMA-DPH. (A) RBC
(4 × 105 cells/mL), platelets (4 × 106 platelets/mL), and PBMC (4 × 105
cells/mL), HUVEC and BCEC (1 × 105 cells/mL) were incubated with
TMA-DPH (54μM) at 25◦C and zeta-potential was measured. Data shown
as mean ± SEM; each group value is an average of at least two
independent measurements. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001 vs.
unlabeled samples, t-test; and #P < 0.05, ##P < 0.01 vs. BCEC, One-Way
ANOVA, Bonferroni’s multiple comparison test. (B) Schematic
representation of TMA-DPH localization in the lipid membrane. The cationic
trimethylamino group of TMA-DPH (in blue) locates near the polar heads of
phospholipids; anionic phospholipids are represented in red and zwitterionic
in yellow.
POPG overcompensation to positive values (from −7.06mV to
5.82mV). Theζ values show that TMA-DPHhas the same effect
on all tested lipidic mixtures (Table 1). This interaction profile is
also perceived in the statistical test applied for ζbuffer vs. ζTMA−DPH
for all lipid mixtures (P < 0.001, Figure 3).
DISCUSSION
Recent developments at the interface of cell biology and bio-
physics have established a new paradigm in protein targeting
and function, in which the electrostatic charge at the sur-
face of a biological membrane has emerged as a key factor
(Yeung et al., 2008, 2009; Goldenberg and Steinberg, 2010).
FIGURE 2 | Relation between zeta-potential and fraction of negatively
charged phospholipids in LUVs constituted by POPC and POPG. LUVs
(200μM) were prepared in PBS buffer and zeta-potential measured at
25◦C. Each group value is an average of at least two independent
measurements; data shown as mean ± SEM. Solid line represents an
exponential function fit to the data. It is noteworthy that a change from
ζ = −10mV to ζ = −15mV (corresponding to a change from
RBC/PBMC/platelets to BCEC) is equivalent to a 2-fold increase in surface
charge density (inserted arrows).
FIGURE 3 | Zeta-potential of membrane model systems of POPC and
POPG. LUVs were incubated with TMA-DPH (54μM) at 25◦C and
zeta-potential was measured. Lipid concentration was kept constant at
200μM. Data shown as mean ± SEM; each group value is an average of at
least two independent measurements. ∗∗P < 0.01 vs. unlabeled samples,
t-test; and #P < 0.05, ##P < 0.01 vs. 15% POPG, One-Way ANOVA,
Bonferroni’s multiple comparison test.
In the specific case of brain targeted compounds, the charge
at the surface of brain endothelium appears to have a role
(dos Santos et al., 1995). However, non-specific interactions are
often disregarded in biomedical investigation and a comprehen-
sive study on membrane surface charge of different mammalian
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cells remains elusive. In this study, we quantified the mem-
brane surface charge of blood components and compared it with
the values obtained for EC from two different origins—brain
and umbilical cord—through dynamic light scattering based
methodologies.
The human RBC membrane has served over the years as a
prototypical model for the structure of the eukaryotic plasma
membrane and therefore it is by far the most studied cell mem-
brane (Daleke, 2008). This justifies that the majority of zeta-
potential measurements by dynamic light scattering studies with
mammalian cells were performed with RBC. The values reported
here for RBC are within the ranges published for two erythro-
cytes’ populations: young and old (Chen et al., 2007; Carvalho
et al., 2011). The considerable effect of TMA-DPH in the zeta-
potential value of these cells suggests that RBC may reduce the
bioavailability of cationic drugs. Regarding platelets, Tatsumi and
colleagues measured ζ = −14 ± 1.64mV (Tatsumi et al., 1992),
which is similar to the value we obtained, despite the fact that
different experimental conditions were used. Our results suggest
that, in a healthy person, the similarity of membrane charge of
blood components and vascular endotheliumwall prevents aggre-
gation and thrombus formation and that this may be an essential
requirement for homeostasis maintenance.
MEMBRANE SURFACE CHARGE AND PHOSPHOLIPIDIC COMPOSITION:
IS THERE A CORRELATION?
The charge of plasma cell membrane is influenced, among other
factors, by the lipid headgroups in the membrane, especially those
that display anionic charge at physiologic pH, such as PS and
phosphatidylinositol (PI). The zeta-potential values obtained for
cells were correlated with the proportion of negatively charged
lipids in the membrane of vesicles. If the main determinant of
membrane surface charge was the lipidic composition, a direct
correlation between these values and the phospholipid compo-
sitions of RBC (Owen et al., 1981), platelets (Owen et al., 1981),
PBMC (Kuliszkiewicz-Janus et al., 2005), BCEC (Tewes and Galla,
2001), and HUVEC (Cansell et al., 1997) could be established.
Values found in the literature for phospholipid compositions of
these cells are summarized in Table 2. The sum of the fractions
of anionic lipids (PS + PI) is different between tested cells, and
the higher values were found for BCEC. This explain in part
why EC from the blood-brain barrier (BBB) have the more neg-
ative membrane charge from all the cells tested but there is no
direct correlation between the percentage of anionic lipids present
in the plasma membrane in the different cells tested and zeta-
potential values (Figure 4). Figure 4 shows that the percentage
of negatively charged lipids in the membranes of cells does not
encompass the anionic net charge density at their surface, BCEC
being an exception. This result can be assigned to: (1) Cell mem-
brane asymmetry in terms of lipid composition—the outer layer
of RBC, for instance, has only a small percentage of anionic lipids,
while the inner layer is much richer (Daleke, 2008), thus reduc-
ing the surface charge density of the RBC. (2) Contribution of
components other than lipids, such as glycolipids, glycoproteins,
and proteins, to surface charge density; this may be the case for
HUVEC as there is a relatively high negative zeta-potential value
for a small fraction of anionic lipids.
BCEC are a very peculiar case, as the lipid composition seems
to suffice to explain their anionicity, which is in agreement with
their function: a highly impermeable barrier with low density
of receptors. Heavy anionicity and lipid exposition contribute
to impermeability (less binding of glycidic or protein groups)
FIGURE 4 | Correlation between the total percentage of negatively
charged phospholipids (PS + PI) in the cells membrane and
zeta-potential value. For PBMC only PS was accounted for (Table 2).
BCEC are a particular case where the high percentage of anionic lipids has
a strongly negative zeta-potential value as a counterpart.
Table 2 | Membrane phospholipid composition of blood components—RBC (Owen et al., 1981), platelets (Owen et al., 1981) and PBMC
(Kuliszkiewicz-Janus et al., 2005)—and endothelial cells—BCEC (Tewes and Galla, 2001) and HUVEC (Cansell et al., 1997).
Phospholipid Blood components Endothelial cells
RBC Platelets PBMC BCEC HUVEC
Phosphatidylcholine (PC) 30.3 40.6 43.4 37.1 53.9
Sphingomyelin (SM) 27.3 19.3 16.9 17.3 22.5
Phosphatidylserine (PS) 13.4 9.3 11.0 8.8 3.0
Phosphatidylinositol (PI) 0.5 2.7
28.7
7.1 6.8
Phosphatidylethanolamine (PE) 28.4 27.9 29.5 13.7
Values shown in percentage, taking into consideration that the sum of PC, SM, PS, PI, and PE proportions represents 100%.
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and prevent unspecific binding or adhesion of blood components
which is significant to prevent thrombus formation. At the same
time, these characteristics reveal a specific property of the BBB
that is important for drug-targeting: lipophilic cationic drugs
are prone to interact with it. Data published by other groups
further support our conclusions. dos Santos et al. (dos Santos
et al., 1995) found that the higher density of heparin sulfate of
BCEC is located at the intercellular junctions, not the cell sur-
face. There are reports of successful drug brain targeting when
cationic compounds are linked to the drug (Tamai et al., 1997).
Leukocyte adhesion and transendothelial migration, both in the
normal state and in inflammatory conditions, were reported to be
lower in BCEC in comparison with other EC (Male et al., 1990;
Pryce et al., 1994), which is in accordance with the anionicity of
BCEC membrane surface.
Compared to blood components (RBC, PBMC, and platelets)
and other EC (HUVEC), BCEC have a higher density of anionic
surface charges and a higher exposition of “naked” lipid surface.
This is a distinctive feature of cell membranes at the BBB level
and contributes to its high selectivity. The results reported here
explain why lipophilic cationic molecules are prone to interact
with the BBB and justify the low adhesion of cells at the brain
level.
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